Increases in mouse uterine heat shock protein levels are a sensitive and specific response to uterotrophic agents. by Papaconstantinou, Andriana D et al.
Environmental Health Perspectives • VOLUME 110 | NUMBER 12 | December 2002 1207
Increases in Mouse Uterine Heat Shock Protein Levels Are a Sensitive and
Speciﬁc Response to Uterotrophic Agents
Andriana D. Papaconstantinou,1 Benjamin R. Fisher,2* Thomas H. Umbreit,2 and Ken M. Brown1
1Department of Biological Sciences, George Washington University, Washington, DC, USA; 2Center for Devices and Radiological Health,
Food and Drug Administration, Rockville, Maryland, USA 
Endocrine disruptors are exogenous agents
that cause adverse health effects in an intact
organism or its progeny consequent to alter-
ations in endocrine function (Olea et al.
1998). A group of these agents act by mimic-
king the action of estrogens and are thus
termed xenoestrogens or estrogen mimics.
Examples of these xenoestrogens are the
industrial chemicals bisphenol A (BPA), an
agent used in the production of polycarbon-
ates and epoxy resins; dibutyl phthalate
(DBP), a plasticizer used in the production of
PVC and in food packaging; and methoxy-
chlor (MXC), a pesticide manufactured to
replace o,p´-DDT. Other xenoestrogens are
naturally produced by plants and are termed
phytoestrogens. These, among others, include
coumestrol (CM).
The estrogenicity of these agents has been
demonstrated in numerous in vitro studies.
BPA, MXC, DBP, and CM compete with
17β-estradiol (E2) for binding to the estrogen
receptor (ER). CM has a higher affinity for
ERβ than for ERα (Kuiper et al. 1998;
Whitten and Patisaul 2001) and is more
potent than BPA or MXC for binding to
both receptor isoforms and activating tran-
scription through the ER (Kuiper et al.
1998). BPA and MXC have similar afﬁnities
for ERα and ERβ (Kuiper et al. 1998). DBP,
although less potent than CM, MXC, or
BPA, competes with E2 for binding to the ER
(Jobling et al. 1995) and increases reporter
gene activity in yeast transfected with the
human ER (Harris et al. 1997). BPA, MXC,
and DBP display weak estrogenic activities in
the E-screen, an assay that measures the pro-
liferation of MCF-7 breast cancer cells in
response to treatments with potential estro-
gen mimics, with the rank order of potency,
BPA > MXC > DBP (Andersen et al. 1999).
In vivo MXC, CM, and BPA mimic E2
actions in the uterus. Increases in uterine
weight have been reported for CM (Hunter et
al. 1999; Markaverich et al. 1995; Tinwell et
al. 2000), MXC (Eroshenko and Cooke 1990;
Laws et al. 2000; Mehmood et al. 2000), and
BPA (Ashby and Tinwell 1998; Laws et al.
2000; Papaconstantinou et al. 2000).
Increases in uterine epithelial cell height have
been shown for CM (Medlock et al. 1995;
O’Connor et al. 2000), for MXC (Eroshenko
and Cooke 1990; Newbold et al. 2001;
Rourke et al. 1991), and for BPA (Markey et
al. 2001; Papaconstantinou et al. 2000;
Steinmetz et al. 1998). In addition, MXC and
BPA stimulate several uterine estrogen-regu-
lated genes. For example, MXC increases lev-
els of uterine peroxidase (Cummings and
Metcalf 1994; Mehmood et al. 2000), creati-
nine kinase (Cummings and Metcalf 1995),
lactoferrin, glucose-6-phosphate dehydroge-
nase (Ghosh et al. 1999), and epidermal
growth factor receptor (Metcalf et al. 1996).
BPA increases levels of uterine insulin growth
factor-I mRNA (Klotz et al. 2000), C3
mRNA (Diel et al. 2000), c-fos mRNA
(Steinmetz et al. 1998), lactoferrin (Markey et
al. 2001), progesterone receptor (PR), and
peroxidase (Gould et al. 1998).
The addition of morphometric or cellular
end points to the rodent uterotrophic assay to
enhance its sensitivity has been suggested
(Ashby 2001; Newbold et al. 2001). We have
previously shown that BPA resembles E2 in
its ability to induce increases in uterine heat
shock protein (hsp) levels, mainly hsp90α
and glucose-regulated protein (grp) 94 and,
to a lesser extent, hsp72 (Papaconstantinou et
al. 2001). We also demonstrated that both E2
and BPA increased levels of hsp90α and
grp94 (Papaconstantinou et al. 2001) at doses
lower than those necessary for a significant
increase in uterine weight (Papaconstantinou
et al. 2000). The use of hsps as biomarkers of
environmental pertubation shows promise
despite some criticisms (Bierkens 2000).
Levels of hsps increase in response to cellular
injury and protein damage to protect the cell
by assisting in the correct folding and pro-
cessing of proteins (Welch 1987). Hsps are
also involved in the signaling of the ER (Pratt
1998) and associate with this receptor
(Chambraud et al. 1990; Landel et al. 1995;
Sabbah et al. 1996). Glucose-regulated pro-
teins (grps) are hsps found in the endoplasmic
reticulum, and their levels increase as a result
of protein damage and in response to glucose
starvation and calcium depletion (Lee 2001).
The ability of estrogen to alter levels of the
uterine hsp90 isoforms hsp90α and hsp90β
has been demonstrated previously (Shyamala
et al. 1989). Estrogen also regulates mRNA
levels of uterine hsp70 (Rivera-Gonzalez et al.
1998; Tang et al. 1995; Wu et al. 1996),
hsp90, and grp94 (Shyamala et al. 1989).
In this study we evaluated the speciﬁcity
of the heat shock response in the uterus and
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Articles
There is increasing consensus that the uterotrophic estrogenicity assay should be coupled with
other morphometric or molecular end points that might enhance its sensitivity. We have previ-
ously shown that bisphenol A (BPA), similarly to 17β-estradiol (E2), increases levels of uterine
heat shock proteins (hsps), mainly hsp90α and glucose-regulated protein (grp) 94. In this study
we investigated whether increases in uterine hsp levels are a speciﬁc response of estrogens or estro-
gen mimics. We therefore examined the ability of a) E2, diethylstilbestrol (DES), and tamoxifen
(TAM); b) the xenoestrogens coumestrol (CM), methoxychlor (MXC), BPA, and dibutyl phtha-
late (DBP); c) the progestin medroxyprogesterone (MED); d) the glucocorticoid dexamethasone
(DEX); and e) phytol (PHY), a precursor to a retinoid X and peroxisome proliferator-activating
receptor agonist, to increase uterine weights and alter uterine morphology and hsp levels. We
showed that DES, TAM, CM, MXC, and BPA signiﬁcantly increased uterine weights and uterine
hsp90α and grp94 levels. Even though the doses of CM, MXC, and BPA used were much higher
than the E2 dose, those treatments resulted in lower increases in uterine weight. On the other
hand, increases in grp94 levels were equal to those induced by E2 treatment. Treatments with
MED, DEX, DBP, or PHY did not signiﬁcantly alter uterine weight or morphology and had no
signiﬁcant effects on uterine hsp levels. The results of this study suggest that only the estrogens
increase uterine hsp90α and grp94 levels, and that this hsp effect is a more sensitive uterotrophic
response than uterine weight increase. Key words: bisphenol A, coumestrol, dexamethasone,
endocrine disruptors, estrogen, heat shock proteins, methoxychlor, medroxyprogesterone, tamox-
ifen, uterotrophism. Environ Health Perspect 110:1207–1212 (2002). [Online 7 October 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1207-1212papaconstantinou/abstract.htmldetermined whether these proteins can be
used as an early indicator of uterotrophism.
We compared the effects on murine uterine
weight, morphology, and hsp levels in
response to exogenous treatments with estro-
genic substances, including diethylstilbestrol
(DES), a synthetic estrogen; tamoxifen
(TAM), a compound that behaves as an ago-
nist for most estrogen responses in the uterus;
and the environmental estrogen mimics
MXC, CM, BPA, and DBP. Furthermore,
because the PR and glucocorticoid receptor
are thought to have a role in the estrogen-
induced increases in uterine weight, especially
through effects on the epithelium (Bigsby and
Cunha 1988), we examined whether agonists
to these receptors alter uterine hsp levels. The
agents chosen include the glucocorticoid dex-
amethasone (DEX), which antagonizes E2-
induced effects in the uterus (Bigsby 1993;
Campbell 1978; Sahlin 1995), and the prog-
estin medroxyprogesterone (MED), which
has higher afﬁnity for the PR than the natural
ligand progesterone and no affinity for the
ER (Terenius 1974). Finally, because the
retinoid X receptor (RXR) and the peroxi-
some proliferator-activated receptor α
(PPARα) can activate estrogen-responsive
genes (Nunez et al. 1997), phytol (PHY), a
proagonist for the RXR (Kitareewan et al.
1996) and the PPARα (Ellinghaus et al.
1999; Lampen et al. 2001), was also included
in this study.
Materials And Methods
Chemicals. Corn oil (CO; vehicle control),
E2, TAM, DES, DEX, MXC (95% purity),
DBP, BPA, MED, and PHY (60% purity)
were purchased from Sigma Chemical Co.
(St. Louis, MO). CM was purchased from
Indoﬁne Chemical Co. (Belle Mead, NJ).
Animals and treatment protocols. All
procedures requiring the use of animals were
conducted according to the National
Institutes of Health Using Animals in
Intramural Research: Guidelines (1998) as
previously described (Papaconstantinou et al.
2000). Ovariectomized female B6C3F1 mice
supplied from Charles River Laboratories
Inc. (Wilmington, MA) were randomly dis-
tributed into treatment groups and housed
in groups of four to six in polypropylene
cages with stainless steel wire lids and heat-
treated chips (Cellu-Dri; Shepherd Specialty
Papers, Kalamazoo, MI), with access to food
(Lab Rodent Diet 5001; PMI Nutrition
International Inc., St. Louis, MO) and water
ad libitum. The animal rooms were main-
tained on a 12-hr light/dark cycle (0600 to
1800 hr) at 23 ± 1°C with 30–50% relative
humidity.
After an acclimation period of 1–2
weeks, animals were dosed subcutaneously
(sc) once a day and for four consecutive days
with solutions of CO (vehicle control), E2 2
µg/kg/day, TAM 1 mg/kg/day, DES 40
µg/kg/day, DEX 1 mg/kg/day, MXC 100
mg/kg/day, CM 10 mg/kg/day, DBP 5,000
mg/kg/day, BPA 100 mg/kg/day, MED 2
mg/kg/day, or PHY 600 mg/kg/day. Doses
for E2 and BPA were based on our previous
observation of increases in uterine weight
(Papaconstantinou et al. 2000) and hsp levels
(Papaconstantinou et al. 2001). The doses 
for TAM (Carthew et al. 1999b), DES
(Farmakalides and Murphy 1984), DEX
(Bigsby and Young 1993), MXC (Laws et al.
2000), and CM (Tinwell et al. 2000) were
based on previous studies of uterotrophic
effects. The dose of DBP was the highest that
we were able to administer and exceeded the
highest dose of 2,000 mg/kg reported by
Zacharewski et al. (1998), which showed no
effect on uterine weight. The dose of MED
was based on our preliminary dose–response
experiment. Finally, because no report exists
on the effects of PHY on the uterus, the dose
of this chemical was the highest that could be
administered. Mice of the first study, which
included treatments with E2, TAM, DES,
and DEX, were 36 days old at the start of the
treatment period, whereas mice in the second
study, which included treatments with E2,
MXC, CM, DBP, BPA, MED, and PHY,
were 49 days old at the start of the experi-
ment. Animals were terminated 24 hr after
the last treatment with carbon dioxide anes-
thesia followed by cervical dislocation.
Uterine weight measurements and uterine
histology. Mice were weighed to the nearest 0.1
g on day 1 and on the day of termination. No
signiﬁcant differences were observed in animal
weights at the beginning or at the end of the
treatment period or in feeding behaviors
between treatment groups during the experi-
ment. Upon termination, uteri were removed,
blotted, and weighed to the nearest 0.1 mg. A
5-mm posteriormost segment of one uterine
horn was fixed overnight in 10% neutral
buffered formalin, dehydrated in a graded
ethanol series, cleared in xylene, embedded in
paraplast, sectioned at 8 µm, and stained with
hematoxylin and eosin. Photographs of uterine
sections were taken on an Olympus BH
microscope equipped with an Olympus C-35A
camera (Olympus, Woodbury, NY) contain-
ing Kodak Ektachrome 160T 35mm film
(Eastman Kodak Company, Rochester NY).
Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis. The uterus remaining after
a section was removed for histology was
pooled with the other 3–5 uteri of the same
treatment group to obtain enough tissue sam-
ple needed for the protein assay, Coomassie
staining, and Western blot analyses. There
were two groups per treatment. The pooled
uteri were homogenized with 0.5 µL of 10
mM Tris buffer, pH 7.4, per milligram of tis-
sue. The homogenates were centrifuged at
15,000 × g for 10 min. The postmitochondr-
ial supernatants (Fowler et al. 1989) were col-
lected, and the total protein concentrations of
the supernatants were determined by the
method of Lowry et al. (1951) with bovine
serum albumen (Sigma) as the standard.
Uterine homogenate supernatants were
diluted to 3.5 mg protein/mL, and 3 µL of
sample (i.e., 10.5 µg/lane) were separated by
12.5% homogeneous sodium dodecyl sulfate-
polyacrylamide gel electrophoresis using 
the Pharmacia Phast System (Pharmacia
Biotechnologies, Piscataway, NJ) as described
by Goering et al. (1992). Equal loading was
veriﬁed by Coomassie staining (Pharmacia) of
proteins in representative gels.
Immunologic detection and densitometric
analysis of heat shock proteins. Electrophoretic
transfer of proteins onto nitrocellulose mem-
branes and immunochemical detections of
hsp72, hsp90α, hsp73, and grp94 were per-
formed as described by Goering et al. (1992).
Briefly, blots were blocked in Tris-buffered
saline (TBS: 20 mM Tris, 500 mM NaCl, pH
7.5) with 4% milk for a minimum of 4 hr.
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Figure 1. Effects of E2 (2 µg/kg/day), TAM (1 mg/kg/day), DES (40 µg/kg/day), DEX (1 mg/kg/day), MXC (100
mg/kg/day), CM (10 mg/kg/day), DBP (5,000 mg/kg/day), BPA (100 mg/kg/day), MED (2 mg/kg/day), or PHY
(600 mg/kg/day) on uterine weight in ovariectomized B6C3F1 mice. (A) Study 1; (B) Study 2. Animals were
treated sc for four consecutive days. Controls received CO (vehicle control). 
*Significant differences from control as determined by one-way ANOVA and the Dunnett’s post hoc test (p < 0.05).
**Signiﬁcant differences from control as determined by one-way ANOVA and the Dunnett’s post hoc test (p < 0.01).
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A BSolutions of stress protein antibodies (Stress-
Gen Biotechnologies, Inc., Vancouver,
British Columbia, Canada) at concentrations
of 1:500 for hsp72, hsp90α, and grp94, or
1:1,200 for hsp73 were prepared in TTBS
(TBS containing 0.05% Tween 20) with 4%
milk. Blots were incubated with hsp antibod-
ies overnight followed by a 3-hr incubation
with alkaline phosphatase conjugated goat
antimouse (Bio-Rad Laboratories, Hercules,
CA), goat antirabbit (Sigma), or rabbit antirat
(Sigma) secondary antibodies. Blots were
scanned with an ARCUS II AGFA scanner,
saved as TIFF images, and imported into the
Kodak Digital Science 1D Image Analysis
Software package (Version 3.0; Eastman
Kodak Company) for densitometric analysis.
For each homogenate the results of two blots
per protein were used to calculate the percent
control band intensity. The averages from the
two uterine homogenates/treatment were
used for the calculation of the means and
standard deviations.
Statistical analysis. Results are expressed
as means ± standard deviations. One way
analysis of variance (ANOVA) was used to
assess the variation of the means among the
treatments. If the variation was greater than
expected by chance alone, Dunnett’s test was
performed for a comparison of pairs of
means. Signiﬁcance was established when the
p-value was less than 0.05.
Results
Uterine weights and histology. Mean uterine
weights signiﬁcantly increased in response to
treatments with the estrogens E2 (p < 0.01)
and DES (p < 0.01), as well as with the mixed
estrogen agonist–antagonist TAM (p < 0.01,
Figure 1). The estrogen-like substances
MXC, CM, and BPA significantly increased
uterine weights, but to a lesser degree than
E2, DES, or TAM (Figure 1). DEX, a gluco-
corticoid; MED, a progestin; PHY, a precur-
sor to phytanic acid, an RXR and PPARα
activator; and DBP, a weak estrogen and
antiandrogen, did not signiﬁcantly alter uter-
ine weights (Figure 1).
In response to treatment with E2 or DES,
the luminal epithelium changed from simple
columnar in control-treated mice (Figure 2A)
to pseudostratified, and the thickness of all
uterine layers increased (Figure 2B and C,
respectively). Treatment with TAM caused
hypertrophy of the luminal epithelium and
stroma, but did not have a significant effect
on the myometrium (Figure 2D). MXC and
BPA caused hypertrophy of uterine epithelial
cells, and mitoses were present in all uterine
layers (Figure 2E and F, respectively). The
effects of the phytoestrogen CM on uterine
morphology resembled those of E2 more
closely than any of the estrogen-like sub-
stances included in the present study. Uterine
epithelium height in CM-treated animals
increased, with most areas consisting of sim-
ple tall columnar epithelium, whereas some
had a pseudostratified appearance (Figure
2G). Furthermore, similar to E2, CM resulted
in the presence of secretory granules and pits
in the luminal epithelium, vacuoles with
degenerating material, and mitotic figures.
Uterine morphology in response to treatment
with DEX, DBP, MED, and PHY (Figure
2H–K, respectively) was similar to that of
CO-treated mice.
Uterine heat shock protein levels. Levels of
uterine hsp90α increased in response to all
treatments that produced a uterotrophic
response (Figure 3A). Of the chemicals exam-
ined, E2, DES, and TAM induced the highest
increases in hsp90α. Speciﬁcally, the increase
of hsp90α levels induced by E2 in the first
study was 15-fold higher than control levels
(p < 0.01). DES and TAM induced increases
to levels approximately 14-fold higher than
control (p < 0.01). MXC and BPA induced
an approximate 5-fold increase, whereas CM
induced an approximate 4-fold increase in
hsp90α levels compared with control. Levels
of uterine hsp90α after treatment with MED
were almost double those of controls, but this
increase was not statistically significant.
Treatment with DEX resulted in a depletion
of hsp90α to undetectable levels.
Levels of grp94 were affected by several of
the treatments. E2, TAM, and DES were com-
parably effective in inducing an increase in
grp94 levels (Figure 3B). The E2-induced
increase in grp94 levels compared with control
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Figure 2. Morphology of the uterus of ovariectomized B6C3F1 mice treated with (A) CO; (B) E2 2 µg/kg/day;
(C) DES 40 µg/kg/day; (D) TAM 1 mg/kg/day; (E) MXC 100 mg/kg/day; (F) BPA 100 mg/kg/day; (G) CM 10
mg/kg/day; (H) DEX 1 mg/kg/day; (I) DBP 5,000 mg/kg/day; (J) MED 2 mg/kg/day; or (K) PHY 600 mg/kg/day.
Epi, stro, and myo in (A) designate uterine epithelium, stroma, and myometrium, respectively. Note key his-
tologic changes for E2 seen in (B): increases in uterine epithelial height, stromal, and myometrial thick-
ness. Scale bar = 25 µm.levels was greater in study 2 than in study 1
(p < 0.01 in both studies). MXC, CM, and
BPA induced an approximate 4-fold increase
in grp94 levels compared with control levels
(p < 0.01). This increase was equal to that
produced by E2 2 µg/kg/day.
As shown in Figure 4A, E2 and TAM
treatments resulted in 9-fold increases in lev-
els of the hsp70 inducible protein hsp72
compared with control levels (p < 0.01). DES
induced a slightly lower increase in uterine
hsp72 levels. None of the estrogen mimics
included in this study effectively increased
levels of hsp72. On the other hand, treat-
ments with DEX, DBP, and MED decreased
hsp72 levels. Levels of the constitutive hsp70
protein (Figure 4B) hsp73 were slightly
increased only by treatment with E2 in study
2 (p < 0.05) and with BPA (p < 0.05).
Discussion
In this study we examined the ability of a
variety of chemicals to alter uterine morphol-
ogy and induce hsp levels. These results are
summarized in Table 1. Based on the effects
listed in this table, TAM 1 mg/kg/day mimic-
ked E2 2 µg/kg/day on all end points with the
exception of the lack of signs of vacuolar
degeneration and a nonsigniﬁcant increase in
hsp73 levels. The ability of TAM to increase
mouse uterine weight (Carthew et al. 1999a;
Chou et al. 1992) and cause hypertrophy of
the uterine epithelium and stroma (Carthew
et al. 1999a) has been previously reported. As
mentioned earlier, in contrast to E2, TAM
was not an agonist in the myometrium. This
is in agreement with a previous study in the
rat (Carthew et al. 1999b). An increase in
uterine hsp72 mRNA levels in ovariec-
tomized Sprague-Dawley rats treated with
TAM 10 mg/kg po has been shown (Rivera-
Gonzalez et al. 1998) and supports the
increase in hsp72 levels seen in the present
study in response to sc treatment with TAM
1 mg/kg/day for 4 days.
As expected from previous studies in
B6C3F1 mice (Farmakalides and Murphy
1984), DES mimicked all the uterotrophic
responses of E2. However, no signs of vacuo-
lar degeneration were seen in uterine sections
of DES-treated mice. DES induced increases
in hsp90α, grp94, and hsp72 levels similar to
E2. MXC, at 100 mg/kg/day, increased uter-
ine wet weight and epithelial height to about
one-third that of E2 2 µg/kg/day. These ﬁnd-
ings resemble those of Laws et al. (2000) and
Mehmood et al. (2000), whose study designs
were similar to the one employed in the pre-
sent study. In addition, MXC significantly
increased levels of hsp90α and grp94. CM
and BPA exhibited E2-like effects on the
majority of the parameters examined. CM
did not induce an increase in hsp73 levels,
and neither compound caused significant
increases in hsp72 levels. An increase in stro-
mal neutrophils in response to sc treatment
with BPA 100 mg/kg/day has been shown pre-
viously in immature Alpk-ApfSD rats
(Matthews et al. 2001). The increase in grp94
levels induced by MXC 100 mg/kg/day, CM
10 mg/kg/day, or BPA 100 mg/kg/day was the
same as that induced by E2 2 µg/kg/day. The
ability of BPA to be as efficacious as E2 in
increasing uterine grp94 levels has been shown
previously (Papaconstantinou et al. 2001).
In contrast to the estrogens or estrogen
mimics examined, DEX induced nonsignifi-
cant decreases in levels of hsp90α and hsp72
and had no effect on uterine weight and mor-
phology. To our knowledge no other study has
examined the effect of DEX on hsp levels in the
uterus. However, DEX regulates levels of hsp90
and hsp70 in glucose-deprived L929 ﬁbroblast
cell cultures (Kasambalides and Lanks 1983).
Furthermore, acute DEX treatment of adult
rat cardiac myocytes resulted in a small but
signiﬁcant increase in levels of hsp72 (Sun et
al. 2000). MED induced a nonsignificant
increase in hsp90α levels, decreased hsp72
levels, and had no effect on uterine weight. As
in our previous study (Papaconstantinou et
al. 2001), the results of this study suggest a
correlation between increases in hsp levels
and uterine proliferation. This is not surpris-
ing, because several studies have shown that
hsps can activate protein kinases and other
cell-signaling proteins that stimulate cell pro-
liferation and inhibit apoptosis (Kaur et al.
2000; Mizuno et al. 2001; Neckers et al.
1999; Zhang et al. 2001). DEX and proges-
terone inhibit uterine epithelial cell prolifera-
tion in both estrogen-independent (Bigsby
and Cunha 1988) and estrogen-dependent
(Bigsby 1993; Campell 1978) models. This
antiproliferative effect of DEX and proges-
terone might possibly explain why DEX and
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Figure 3. Western analysis of (A) hsp90α and (B) grp94 protein levels in 15,000 × g homogenate super-
natants from pooled uterine tissues of ovariectomized B6C3F1 mice. Animals were treated sc for four con-
secutive days with CO (vehicle control), E2 (2 µg/kg/day), TAM (1 mg/kg/day), DES (40 µg/kg/day), DEX (1
mg/kg/day), MXC (100 mg/kg/day), CM (10 mg/kg/day), DBP (5,000 mg/kg/day), BPA (100 mg/kg/day), MED
(2 mg/kg/day), or PHY (600 mg/kg/day). The bar graphs represent the results of the densitometric analysis
of Western blots of hsp90α and grp94. Averages from two Western blots for each protein were calculated.
The two averages obtained from the two homogenates per treatment were used for calculation of the
means and standard deviations, and the results are expressed as percent of control.
*Statistically signiﬁcant difference from control as determined by one-way ANOVA and the Dunnett’s post hoc test (p <
0.05). **Statistically signiﬁcant difference from control as determined by one-way ANOVA and the Dunnett’s post hoc test
(p < 0.01).
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**MED treatments in this study decreased lev-
els of hsp72. The subtle nonsigniﬁcant increase
in hsp90α levels in response to treatment with
MED may be an indicator of the potential of
this agent to increase uterine weight when
given at a dose higher than that used here (Actis
et al. 1998). PHY, the precursor to the PPAR
and RXR agonist phytanic acid, had no
effects on any of the parameters examined,
despite several studies that have demonstrated
the binding of RXR (Joyeux et al. 1996;
Klinge et al. 1997) or the PPAR/RXR het-
erodimer (Keller et al. 1995) to the estrogen
response element and support the ability of
these receptors to activate estrogen-responsive
genes (Nunez et al. 1997).
Collectively, results of this study demon-
strate that all the ER agonists except DBP
increased uterine hsp levels. This argues for a
role of the ER in the regulation of these
genes in the uterus and is supported by our
previous observations that E2 and BPA-
induced increases in hsp levels are antago-
nized by the ER antagonist ICI 182,780
(Papaconstantinou et al. 2001). Whether ER
agonists directly affect the transcriptional
activity of theses hsp genes is uncertain.
Although these genes do not contain estrogen
response elements, promoter sequences on
many estrogen responsive genes that bind ERs
(Beato et al. 1995), they do contain Sp1 pro-
moter sequences (Perry et al. 1994; Vourc’h et
al. 1989), which drive ER-mediated transcrip-
tion of hsp27 (Porter et al. 1997). All chemi-
cals that induced uterine proliferation
increased hsp90α and grp94 levels, but not all
produced a signiﬁcant increase in hsp72 levels.
Furthermore, MXC, CM, and BPA were as
efficacious as E2 in increasing grp94 levels.
This observation, together with the results of
our previous study that demonstrated
increased levels of grp94 by BPA at doses 40
times lower than those needed to increase
uterine weights (Papaconstantinou et al.
2001), suggests that this protein is a more sen-
sitive marker of estrogenic uterotrophic effects
than increases in organ weight.
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Table 1. Summary of effects on all uterine parameters examined.
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